脂质体布比卡因局部浸润镇痛改善全膝关节置换术后疼痛评分并减少阿片类药物使用:一项随机对照试验结果
PILLAR研究将140例初次单侧全膝关节置换术患者随机分为脂质体布比卡因(LB)266 mg/20 mL混合0.5%盐酸布比卡因20 mL局部浸润镇痛组或不含LB的0.5%盐酸布比卡因20 mL局部浸润镇痛组。结果显示LB组术后12-48小时视觉模拟量表疼痛强度评分曲线下面积低于对照组,术后0-48小时阿片类药物总消耗量也低于对照组,无阿片类药物使用患者比例更高,首次阿片类药物救援时间更长。
要点
- LB组术后12-48小时疼痛评分AUC为180.8,对照组为209.3(LS均值差-26.88,P=0.0381)。
- LB组术后0-48小时阿片类药物总消耗LS均值为18.7 mg,对照组为84.9 mg(LS比值0.220,P=0.0048)。
- LB组无阿片类药物使用患者比例更高(P<0.01),首次阿片类药物救援时间更长(P=0.0230),两组耐受性相似。
核心结论
- 在采用针对全膝关节置换术的优化技术进行局部浸润镇痛时,含LB的方案显著改善术后疼痛、减少阿片类药物消耗并延长首次阿片类药物救援时间,无阿片类药物使用患者更多,且无意外安全性问题。
研究设计与样本
- PILLAR研究为随机对照试验,纳入140例初次单侧全膝关节置换术患者,随机分为LB 266 mg/20 mL混合0.5%盐酸布比卡因20 mL局部浸润镇痛组或不含LB的0.5%盐酸布比卡因20 mL局部浸润镇痛组。
- 研究采用标准化浸润技术和标准化多模式疼痛管理方案。
- 共同主要疗效终点为术后12-48小时视觉模拟量表疼痛强度评分曲线下面积(AUC12-48)和术后0-48小时阿片类药物总消耗量。
主要发现
- LB组术后12-48小时视觉模拟量表疼痛强度评分AUC均值为180.8,对照组为209.3(LS均值差-26.88,P=0.0381)。
- LB组术后0-48小时阿片类药物总消耗LS均值为18.7 mg,对照组为84.9 mg(LS比值0.220,P=0.0048)。
- LB组无阿片类药物使用患者比例显著更高(P<0.01),首次阿片类药物救援时间显著更长(P=0.0230)。
- 两组治疗耐受性相似。
关键数值与推荐
- LB组术后12-48小时疼痛评分AUC均值180.8 vs 对照组209.3(LS均值差-26.88,P=0.0381)。
- LB组术后0-48小时阿片类药物总消耗LS均值18.7 mg vs 对照组84.9 mg(LS比值0.220,P=0.0048)。
- LB组无阿片类药物使用患者比例更高(P<0.01),首次阿片类药物救援时间更长(P=0.0230)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Local infiltration analgesia (LIA) with liposomal bupivacaine (LB) in patients undergoing total knee arthroplasty (TKA) has yielded mixed results. The PILLAR study, which was designed to minimize limitations associated with previous studies, compared the effects of LIA with or without LB on pain scores, opioid consumption, including proportion of opioid-free patients, time to first opioid rescue, and safety after primary unilateral TKA. METHODS: Patients (N = 140) were randomized to LIA with LB 266 mg/20 mL (admixed with bupivacaine HCl 0.5%, 20 mL) or LIA with bupivacaine HCl 0.5%, 20 mL. Standardized infiltration techniques and a standardized multimodal pain management protocol were used. The coprimary efficacy endpoints were area under the curve (AUC) of visual analog scale pain intensity scores 12-48 hours (AUC12-48) postsurgery and total opioid consumption 0-48 hours postsurgery. RESULTS: Mean AUC12-48 of visual analog scale pain intensity score was 180.8 with LB and 209.3 without LB (least squares [LS] mean treatment difference -26.88, P = .0381). LS mean total opioid consumption 0-48 hours postsurgery was 18.7 mg with and 84.9 mg without LB (LS ratio 0.220, P = .0048). Significant differences in favor of LB were observed for the percentage of opioid-free patients (P < .01) and time to first opioid rescue (P = .0230). Treatments were similarly well tolerated. CONCLUSION: This study provides data on LIA with LB administered using optimal techniques specific to TKA. In this setting, LIA with LB significantly improved postsurgical pain, opioid consumption, and time to first opioid rescue, with more opioid-free patients and no unexpected safety concerns.
引用
- Mont MA, Beaver WB, Dysart SH, et al. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial. J Arthroplasty. 2017. PMID: 28802777. doi:10.1016/j.arth.2017.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。